Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Other Gross PP&E Adjustments (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with $460727.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 31.04% to $460727.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $460727.0, a 31.04% increase, with the full-year FY2024 number at -$481009.0, up 18.75% from a year prior.
  • Other Gross PP&E Adjustments was $460727.0 for Q3 2025 at bioAffinity Technologies, up from $364987.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $460727.0 in Q3 2025 to a low of -$616782.0 in Q1 2024.
  • A 4-year average of -$21773.0 and a median of $75107.0 in 2022 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: tumbled 9120.48% in 2023, then soared 178.82% in 2024.
  • bioAffinity Technologies' Other Gross PP&E Adjustments stood at $6563.0 in 2022, then crashed by 9120.48% to -$592014.0 in 2023, then increased by 18.75% to -$481009.0 in 2024, then skyrocketed by 195.78% to $460727.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Other Gross PP&E Adjustments are $460727.0 (Q3 2025), $364987.0 (Q2 2025), and $423611.0 (Q1 2025).